Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System (CAuSMIc II)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2008 by Mytogen, Inc..
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Mytogen, Inc.
ClinicalTrials.gov Identifier:
NCT00626314
First received: February 21, 2008
Last updated: February 28, 2008
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: August 2010
  Estimated Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)